{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:16:38Z","timestamp":1781082998559,"version":"3.54.1"},"reference-count":10,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JOP"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:p> Wider use of FDA anti-counterfeit initiatives, limiting pharmaceutical suppliers to reputable distributors, and educating providers and patients about signs of counterfeit drugs can improve the safety of cancer pharmaceuticals. <\/jats:p>","DOI":"10.1200\/jop.2011.000325","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T22:51:03Z","timestamp":1331938263000},"page":"84-90","source":"Crossref","is-referenced-by-count":15,"title":["Caveat Oncologist: Clinical Findings and Consequences of Distributing Counterfeit Erythropoietin in the United States"],"prefix":"10.1200","volume":"8","author":[{"given":"Zaina P.","family":"Qureshi","sequence":"first","affiliation":[{"name":"Tulane Cancer Center, Tulane Medical School, New Orleans, LA; South Carolina Center of Economic Excellence for Medication Safety and Efficacy and the Southern Network on Adverse Reactions, University of South Carolina, Columbia, SC; Northwestern University, Chicago, IL; University of New Mexico; Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy, Albuquerque, NM; and Lead Horse Technologies, Junction City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeAnn","family":"Norris","sequence":"additional","affiliation":[{"name":"Tulane Cancer Center, Tulane Medical School, New Orleans, LA; South Carolina Center of Economic Excellence for Medication Safety and Efficacy and the Southern Network on Adverse Reactions, University of South Carolina, Columbia, SC; Northwestern University, Chicago, IL; University of New Mexico; Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy, Albuquerque, NM; and Lead Horse Technologies, Junction City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Sartor","sequence":"additional","affiliation":[{"name":"Tulane Cancer Center, Tulane Medical School, New Orleans, LA; South Carolina Center of Economic Excellence for Medication Safety and Efficacy and the Southern Network on Adverse Reactions, University of South Carolina, Columbia, SC; Northwestern University, Chicago, IL; University of New Mexico; Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy, Albuquerque, NM; and Lead Horse Technologies, Junction City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June M.","family":"McKoy","sequence":"additional","affiliation":[{"name":"Tulane Cancer Center, Tulane Medical School, New Orleans, LA; South Carolina Center of Economic Excellence for Medication Safety and Efficacy and the Southern Network on Adverse Reactions, University of South Carolina, Columbia, SC; Northwestern University, Chicago, IL; University of New Mexico; Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy, Albuquerque, NM; and Lead Horse Technologies, Junction City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Tulane Cancer Center, Tulane Medical School, New Orleans, LA; South Carolina Center of Economic Excellence for Medication Safety and Efficacy and the Southern Network on Adverse Reactions, University of South Carolina, Columbia, SC; Northwestern University, Chicago, IL; University of New Mexico; Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy, Albuquerque, NM; and Lead Horse Technologies, Junction City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Raisch","sequence":"additional","affiliation":[{"name":"Tulane Cancer Center, Tulane Medical School, New Orleans, LA; South Carolina Center of Economic Excellence for Medication Safety and Efficacy and the Southern Network on Adverse Reactions, University of South Carolina, Columbia, SC; Northwestern University, Chicago, IL; University of New Mexico; Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy, Albuquerque, NM; and Lead Horse Technologies, Junction City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishvas","family":"Garg","sequence":"additional","affiliation":[{"name":"Tulane Cancer Center, Tulane Medical School, New Orleans, LA; South Carolina Center of Economic Excellence for Medication Safety and Efficacy and the Southern Network on Adverse Reactions, University of South Carolina, Columbia, SC; Northwestern University, Chicago, IL; University of New Mexico; Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy, Albuquerque, NM; and Lead Horse Technologies, Junction City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Stafkey-Mailey","sequence":"additional","affiliation":[{"name":"Tulane Cancer Center, Tulane Medical School, New Orleans, LA; South Carolina Center of Economic Excellence for Medication Safety and Efficacy and the Southern Network on Adverse Reactions, University of South Carolina, Columbia, SC; Northwestern University, Chicago, IL; University of New Mexico; Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy, Albuquerque, NM; and Lead Horse Technologies, Junction City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Lee","family":"Bennett","sequence":"additional","affiliation":[{"name":"Tulane Cancer Center, Tulane Medical School, New Orleans, LA; South Carolina Center of Economic Excellence for Medication Safety and Efficacy and the Southern Network on Adverse Reactions, University of South Carolina, Columbia, SC; Northwestern University, Chicago, IL; University of New Mexico; Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy, Albuquerque, NM; and Lead Horse Technologies, Junction City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038231"},{"key":"B5","unstructured":"K Eban :  Dangerous Doses: How Counterfeiters Are Contaminating America's Drug Supply 2005 New York, NY Harcourt"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/0897190006293517"},{"key":"B7","first-page":"426","volume":"43","year":"1986","journal-title":"Am J Hosp Pharm"},{"key":"B17","unstructured":"Counterfeit Drug Task Force Report THE COUNTERFEIT DRUG TASK FORCE 2003 US Food and Drug Administration 10 http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm174399.htm"},{"key":"B18","unstructured":"Counterfeit Drug Taskforce: Counterfeit Drug Task Force Report COMBATING COUNTERFEIT DRUGS 2004 US Food and Drug Administration 2 http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm173231.htm"},{"key":"B19","unstructured":"Counterfeit Drug Task Force Report Combating Counterfeit Drugs: A Report of the Food and Drug Administration Annual Update 2005 US Food and Drug Administration 5 http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm172935.htm"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/0897190006292946"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806450"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60663-7"}],"container-title":["Journal of Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JOP.2011.000325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:39:34Z","timestamp":1653525574000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JOP.2011.000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1200\/JOP.2011.000325"],"URL":"https:\/\/doi.org\/10.1200\/jop.2011.000325","relation":{},"ISSN":["1554-7477","1935-469X"],"issn-type":[{"value":"1554-7477","type":"print"},{"value":"1935-469X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}